KAMADA LTD (KMDA) Stock Price & Overview
NASDAQ:KMDA • IL0010941198
The current stock price of KMDA is 8.96 USD. Today KMDA is down by -0.22%. In the past month the price increased by 8.21%. In the past year, price increased by 24.79%.
KMDA Key Statistics
- Market Cap
- 516.813M
- P/E
- 24.89
- Fwd P/E
- 18.69
- EPS (TTM)
- 0.36
- Dividend Yield
- 2.26%
KMDA Stock Performance
KMDA Stock Chart
KMDA Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to KMDA. When comparing the yearly performance of all stocks, KMDA is one of the better performing stocks in the market, outperforming 85.05% of all stocks.
KMDA Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to KMDA. While KMDA belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.
KMDA Earnings
On November 10, 2025 KMDA reported an EPS of 0.09 and a revenue of 47.01M. The company missed EPS expectations (-4.61% surprise) and beat revenue expectations (0.61% surprise).
KMDA Forecast & Estimates
9 analysts have analysed KMDA and the average price target is 13.26 USD. This implies a price increase of 47.99% is expected in the next year compared to the current price of 8.96.
For the next year, analysts expect an EPS growth of 44.17% and a revenue growth 12.37% for KMDA
KMDA Groups
Sector & Classification
KMDA Financial Highlights
Over the last trailing twelve months KMDA reported a non-GAAP Earnings per Share(EPS) of 0.36. The EPS increased by 28.57% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 11.7% | ||
| ROA | 5.42% | ||
| ROE | 7.71% | ||
| Debt/Equity | 0.04 |
KMDA Ownership
KMDA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 15.3 | 402.17B | ||
| AMGN | AMGEN INC | 16.45 | 203.213B | ||
| GILD | GILEAD SCIENCES INC | 16.81 | 182.029B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 25.75 | 117.075B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.51 | 82.631B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 43.21 | 42.915B | ||
| INSM | INSMED INC | N/A | 30.852B | ||
| NTRA | NATERA INC | N/A | 29.086B | ||
| BIIB | BIOGEN INC | 11.72 | 27.626B | ||
| UTHR | UNITED THERAPEUTICS CORP | 17.94 | 23.193B | ||
| MRNA | MODERNA INC | N/A | 22.014B | ||
| EXAS | EXACT SCIENCES CORP | 340.08 | 19.797B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.775B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About KMDA
Company Profile
Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Company Info
IPO: 2005-08-01
KAMADA LTD
2 Holtzman St., Science Park
Rehovot 7670402 IL
CEO: Amir London
Employees: 374
Phone: 97289406472
KAMADA LTD / KMDA FAQ
Can you describe the business of KAMADA LTD?
Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
What is the current price of KMDA stock?
The current stock price of KMDA is 8.96 USD. The price decreased by -0.22% in the last trading session.
What is the dividend status of KAMADA LTD?
KAMADA LTD (KMDA) has a dividend yield of 2.26%. The yearly dividend amount is currently 0.
How is the ChartMill rating for KAMADA LTD?
KMDA has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Which stock exchange lists KMDA stock?
KMDA stock is listed on the Nasdaq exchange.
Can you provide the market cap for KAMADA LTD?
KAMADA LTD (KMDA) has a market capitalization of 516.81M USD. This makes KMDA a Small Cap stock.
What is the ownership structure of KAMADA LTD (KMDA)?
You can find the ownership structure of KAMADA LTD (KMDA) on the Ownership tab.